DePuy Synthes Archives - Page 3 of 4 - Medical Design Sourcing

How a robot revolution will reduce the physical burdens of orthopedic surgery

Johnson & Johnson’s VELYS robotic system for orthopedic surgery [Image courtesy of Johnson & Johnson]

DePuy Synthes Worldwide President of Joint Reconstruction Andrew Ekdahl thinks robotic-assisted systems will be a big help for orthopedic surgeons who are busier than ever.

Innovations in surgical instruments and capabilities have substantially increased the volume of procedures being performed on any given day — and increased the physical burden on orthopedic surgeons.

Many years ago, the busiest surgeons would conduct three orthopedic procedures per week, said Andrew Ekdahl, worldwide president of joint reconstruction at DePuy Synthes. But now those busiest surgeons are performing more than nine procedures per day, multiple days each week.

“The physical burden of orthopedics has gone up dramatically. If we can do things to reduce that physical burden, that’s innovation,…

DePuy Synthes acquires CrossRoads Extremity Systems

Johnson & Johnson’s (NYSE:JNJ) DePuy Synthes announced that it acquired CrossRoads Extremity Systems.

Tennessee-based CrossRoads Extremity Systems develops a range of procedure-specific, sterile-packed implants and instrumentation systems cleared for lower extremity indications. The company grew into a leader in the foot and ankle space with backing from HealthpointCapital.

According to a news release, in acquiring CrossRoads, DePuy Synthes adds a number of differentiated products to its portfolio, including the miniBunion 3D, dynaBunion 4D and DynaFoce staple compression plates.

CrossRoads designed miniBunion as a minimally invasive solution for metatarsal bone osteotomy, while it developed the dynaBunion lapidus system as an option for lapidus bunionectomy and a provider of instrumentation and implants to correct bunions in four dimensions through smaller incisions.

DynaForce staple compression plates combine stability with dynamic continuou…

DePuy Synthes buys OrthoSpin and its robotic external fixation system

Johnson & Johnson’s (NYSE:JNJ) DePuy Synthes, through its Synthes GmbH affiliate, announced today that it acquired OrthoSpin.

Israel-based OrthoSpin develops a robot-assisted external fixation system for orthopedic treatments. The platform is used in conjunction with DePuy Synthes’ Maxframe multi-axial correction system, an external ring fixation system.

OrthoSpin received FDA clearance for its second generation, robotic, digitally-enabled G2 external fixation system in January of this year.

According to a news release, the acquisition highlights J&J’s efforts to advance innovation in medtech, with the company having kept tabs on OrthoSpin over the years. OrthoSpin raised $3 million for the external fixation system in a July 2018 Series A funding round led by J&J. The company also led OrthoSpin’s Series B in March 2020.

DePuy Synthes introduced its Maxframe system in 2017 and recently launched new frame innovati…

J&J Institute, DePuy Synthes launch mobile training lab for Velys robotic surgery platform

Image from Depuy Synthes/Johnson & Johnson

DePuy Synthes and the Johnson & Johnson Institute launched a mobile training lab for surgeons using the Velys robot-assisted platform.

The first-of-its-kind mobile training lab offering next-generation training directly to surgeons and their teams was launched in Sydney, Australia, according to a news release.

DePuy Synthes, the orthopaedics business unit of Johnson & Johnson, will offer on-site access to the training along with virtual reality-based operating environments and real-time collaboration at the Velys Digital Surgery Mobile Lab. All of the offerings intend to equip Australian orthopaedic surgeons with the capabilities to proficiently use the Velys robotic-assisted solution.

Velys, a first-of-its kind, table-mounted solution offers an efficient design capable of integrating into any operating room, the company said. DePuy said it adapts to a surgeon’s workflow, offers control they are used…

Depuy Synthes launches Inhance shoulder system

Johnson & Johnson’s (NYSE:JNJ) Depuy Synthes this week announced that it has launched its Inhance should system.

Raynham, Mass.-based Depuy Synthes designed the Inhance system as a fully integrated shoulder arthroplasty system. It has an intuitive stemless-first surgical approach that offers surgeons the ability to seamlessly transition from stemless to stemmed implants during surgical procedures, according to the company.

“Advancements in shoulder arthroplasty have enabled a broader range of surgical treatment over the past decade but have increased the complexity and cost of preparing for each surgical case,” J. Michael Wiater, vice chairman and chief of shoulder surgery at Oakland University William Beaumont School of Medicine, said in a news release. “The Inhance Shoulder System can empower surgeons to seamlessly alter their surgical flow, while simultaneously keeping their focus on the patient, and has the potential to reduce OR time.”

The…

DePuy Synthes launches next-gen variable angle clavicle plate system

[Image from DePuy Synthes]Johnson & Johnson (NYSE:JNJ) unit DePuy Synthes announced that it launched the 2.7 mm variable angle locking compression plate (VA LCP) clavicle plate system.

West Chester, Pa.-based DePuy Synthes designed the VA LCP clavicle plate system for the treatment of lateral, shaft and medial fractures for small, medium and large clavicles.

Get the full story at our sister site, Medical Design & Outsourcing.

DePuy Synthes launches next-gen variable angle clavicle plate system

[Image from DePuy Synthes)

Johnson & Johnson (NYSE:JNJ) unit DePuy Synthes announced that it launched the 2.7 mm variable angle locking compression plate (VA LCP) clavicle plate system.

West Chester, Pa.-based DePuy Synthes designed the VA LCP clavicle plate system for the treatment of lateral, shaft and medial fractures for small, medium and large clavicles.

According to a news release, the new system offers plate shapes that reflect the correlation between patient stature and clavicle size to match the bow and contour of the clavicle while accommodating a wide range of anatomic variability of the clavicle with thinner plates, a more accurate plate-to-bone fit and reduced prominence.

DePuy Synthes looked at more than 600 clavicle CT scans from a broad-based patient population while analyzing 15 different parameters on the bone to identify the correlation between patient height and clavicle sh…

The 10 largest orthopedic device companies in the world

[Image from Pixaby]Pent-up demand could make orthopedic devices a hot space in 2021.

The COVID-19 pandemic was especially brutal for the orthopedic device industry. Many of the largest companies in the space saw double-digit percentage declines in revenue in 2020. Health providers delayed or canceled elective procedures to focus on the pandemic, and patients stayed away in droves.

It’s a new year now, though, and vaccines are rolling out. People don’t want to live with a bad knee or hip or back forever. Growth will eventually return for the industry, and orthopedic device companies are positioning themselves to be ready.

Rather than hunkering down during the pandemic, many ortho device companies chose shop for new technologies and major M&A deals. They’re reorganizing and launching new products ranging from surgical robots to smart implants.

Read on and discover the latest about the world’s 10 largest orthopedic device companies.

Next>>

The 10 largest orthopedic device companies in the world

[Image from Pixaby]

Pent-up demand could make orthopedic devices a hot space in 2021.

The COVID-19 pandemic was especially brutal for the orthopedic device industry. Many of the largest companies in the space saw double-digit percentage declines in revenue in 2020. Health providers delayed or canceled elective procedures to focus on the pandemic, and patients stayed away in droves.

It’s a new year now, though, and vaccines are rolling out. People don’t want to live with a bad knee or hip or back forever. Growth will eventually return for the industry, and orthopedic device companies are positioning themselves to be ready.

Rather than hunkering down during the pandemic, many ortho device companies chose shop for new technologies and major M&A deals. They’re reorganizing and launching new products ranging from surgical robots to smart implants.

Read on and discover the latest about the w…

9 medical devices you should keep an eye out for in 2021

The medical device industry weathered the COVID-19 pandemic well — and is now set to roll out a host of innovations in 2021.

Economists generally expect the U.S. to see a boom as we emerge from the pandemic and resulting recession. Medtech companies appear set to ride the wave this year, with plans to seek approval or launch a wide range of new products.

Think surgical robotics, smart orthopedic implants, neurostimulation, single-use scopes and much more.

Here are nine devices to especially keep an eye out for this year.

Next>>

DTW Podcast Ep. 42 – How the pandemic has accelerated, slowed medtech innovation

The pandemic has accelerated innovation in many ways but the physical pressures on entrepreneurs, innovators and engineers is very real.

In this episode of the DeviceTalks Weekly Podcast, a panel representing early-stage and tech transfer efforts explain how they’re helping individuals and young companies work through the unique challenges of the time, including finding capital, working with corporates, understanding opportunities in a changing healthcare market, seeing the silver linings

Guests include

Jennifer McCaney, PhD,,co-executive director, UCLA Biodesign Jackie Mejia, PhD, director, gBeta Medtech Scott Morley, director, office of economic partnerships, University of Pittsburgh

This conversation is a condensed version of our Jan. 19 DeviceTalks Tuesday. Go to DeviceTalks.com to watch the entire on-demand presentation.

Co-host Chris Newmarker, executive editor of MassDevice, also shares his top 5 stories of the week, aka, #Newmarker…

DTW Podcast Ep. 42 – How the pandemic has accelerated, slowed medtech innovation

The pandemic has accelerated innovation in many ways but the physical pressures on entrepreneurs, innovators and engineers is very real.

In this episode of the DeviceTalks Weekly Podcast, a panel representing early-stage and tech transfer efforts explain how they’re helping individuals and young companies work through the unique challenges of the time, including finding capital, working with corporates, understanding opportunities in a changing healthcare market, seeing the silver linings

Guests include

Jennifer McCaney, PhD,,co-executive director, UCLA Biodesign Jackie Mejia, PhD, director, gBeta Medtech Scott Morley, director, office of economic partnerships, University of Pittsburgh

This conversation is a condensed version of our Jan. 19 DeviceTalks Tuesday. Go to DeviceTalks.com to watch the entire on-demand presentation.

Co-host Chris Newmarker, executive editor of MassDevice, also shares his top 5 stories of the week, aka, #Newmarker…